Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Telix’s brain-cancer imaging agent Pixclara handed to FDA for review
News
ASX Lunch Wrap: Jumbo, Inghams, Accent sink, ending ASX winning streak
News
ASX Small Caps Lunch Wrap: We’re not living in a Materials world anymore. At least not today
Health & Biotech
ASX Health Stocks: HitIQ’s mouthguard approved by World Rugby; Neurotech reports positive results
News
Closing Bell: Markets are in revolution and the ASX just stormed its psychological Bastille
News
Closing Bell: This ASX looks ready to cut its own records after latest Wall Street highs
News
Closing Bell: Most ASX sectors flashing red today, as RAU makes solid market debut
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Health stocks flat as ACCC scrutinises Sigma and Chemist Warehouse merger
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: INOVIQ pops 45pc after revealing breakthrough exosome therapy to kill breast cancer
News
Traders’ Diary: Everything you need to get ready for the week ahead
Health & Biotech
ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System
Health & Biotech
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
Health & Biotech
ASX Health Stocks: Telix says TLX592 shows promise in prostate cancer battle
Health & Biotech
Top ASX biotechs catching the eye of analysts and fund managers in 2024 – Part 1
Health & Biotech
ASX Health Stocks: Island Pharma releases data on dengue fever drug, IDT signs $3m+ deal with Sanofi
News
